首页> 外文期刊>nuclear medicine and molecular imaging >Langerhans' Cell Histiocytosis Masquerading as Metastatic Papillary Thyroid Cancer on F-18 FDG PET/CT: Diagnostic Dilemma Solved by PET/CT-Guided Biopsy
【24h】

Langerhans' Cell Histiocytosis Masquerading as Metastatic Papillary Thyroid Cancer on F-18 FDG PET/CT: Diagnostic Dilemma Solved by PET/CT-Guided Biopsy

机译:F-18 FDG PET/CT 上伪装成转移性甲状腺状癌的朗格汉斯细胞组织细胞增生症:PET/CT 引导活检解决的诊断困境

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We present a case of papillary thyroid cancer (post-thyroidectomy status) on regular treatment with suppressive Levothyroxine therapy. On follow-up at 6months after radioactive iodine ablation for remnant thyroid tissue, her thyroglobulin, and anti-thyroglobulin levels were 0.06ng/ml and 670IU/ml, respectively. Low-dose whole-body I-131 scan was negative. To look for the cause of isolated increased anti-thyroglobulin level, a whole-body F-18-FDG PET/CT was done which revealed multiple FDG-avid lytic skeletal lesions suggestive of metastases. For confirmation of diagnosis, F-18-FDG PET/CT-guided metabolic biopsy was done, which revealed Langerhans' cell histiocytosis on histopathological examination.
机译:我们介绍了一例甲状腺状癌(甲状腺切除术后状态)接受抑制性左旋甲状腺素抑制治疗的病例。在对残余甲状腺组织进行放射性碘消融术后 6 个月的随访中,她的甲状腺球蛋白和抗甲状腺球蛋白水平分别为 0.06ng/ml 和 670IU/ml。低剂量全身 I-131 扫描呈阴性。为了寻找孤立性抗甲状腺球蛋白水平升高的原因,进行了全身 F-18-FDG PET/CT 检查,结果显示多处 FDG 亲和性裂解性骨骼病变提示转移。为了确诊,进行了 F-18-FDG PET/CT 引导的代谢活检,在组织病理学检查中显示朗格汉斯细胞组织细胞增生症。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号